Aurobindo Pharma Share Price Today | Stock Price & Aurobindo Pharma Share Screener

Track the current stock price of Aurobindo Pharma with an interactive chart. Analyse AUROPHARMA share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Aurobindo Pharma stock quote in one place.

The quote of ₹1,578.80 sits between the 52-week low of ₹1,085.00 and the 52-week high of ₹1,734.00, and the latest session moved -2.63% from the previous close.

Screen Aurobindo Pharma company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for AUROPHARMA shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Pharmaceuticals industry, with M R Kumar listed as chairperson or CEO, and it trades under ISIN INE406A01037.

Aurobindo Pharma Limited (APL) is an Indian pharmaceutical company founded in 1986. It manufactures and markets active pharmaceutical ingredients, generic formulations, and branded pharmaceuticals globally. APL specializes in various therapeutic areas including antibiotics, antiretrovirals, cardiovascular, central nervous system, and gastroenterological products. The company operates 24 manufacturing plants worldwide and has...more

Classification

Identifiers and Leadership

Screen AUROPHARMA balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹58,502, up from ₹49,785 in 2025.

Latest statistics put total assets at ₹58,502 and shareholder funds at ₹37,883, with a leverage ratio of 0.23.

Screen Aurobindo Pharma income statement and profit fundamentals. Analyze AUROPHARMA quarterly results. Aurobindo Pharma reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For 2026-Mar, revenue was ₹8,869 and net profit was ₹921, equal to earnings per unit of ₹15.86, at an operating margin of 19%.

In that period expenses were ₹7,103, interest cost ₹98 and tax ₹370. The next period listed, 2026-Jun, shows revenue of ₹9,370 and net profit of ₹1,032.

Screen AUROPHARMA cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities generated ₹5,526, and net cash flow was an inflow of ₹1,628.

Over the same period, investing activities used ₹2,630 and financing activities used ₹1,269.

See Aurobindo Pharma shareholding pattern with promoter, FII, and DII holdings. Check Aurobindo Pharma promoter holding and ownership changes for AUROPHARMA on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Mar, promoters held 51.82%, foreign institutions 15.24%, domestic institutions 25.87% and the public 5.74%, spread across 241,298 shareholders.

The shareholder count was 241,298 in 2026-Mar, compared with 239,073 in 2026-Jun.

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Aurobindo Pharma. Aurobindo Pharma dividend yield can be compared with peers and other stocks in the market.

The latest dividend recorded was ₹4.00 per unit for 2026-March, a yield of 0.24%, compared with ₹0.00 for 2025-March.

Dividends are listed for 10 periods, with the three most recent payouts at ₹4.00, ₹0.00 and ₹4.50 per unit.

See which indices include Aurobindo Pharma stock. Check AUROPHARMA index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

The company is listed in 30 indices, including BSE 1000.

Among the benchmarks tracked are BSE 1000, BSE 200 EQUAL WEIGHT, BSE INDEX BSE HC, BSE INDEX BSE200.

Get Aurobindo Pharma corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Aurobindo Pharma stock events that may affect AUROPHARMA share price, along with derivatives, futures and options activity and sector gainers.

15 corporate actions are listed, the most recent entry being Annual General Meeting dated August 27, 2026, with a record date of August 27, 2026.

It is followed by Quarterly Result Announcement dated August 5, 2026 and Quarterly Result Announcement dated May 21, 2026.

Screen AUROPHARMA competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Screen AUROPHARMA latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated October 14, 2026.

The next most recent announcements are dated October 5, 2026 and October 3, 2026.

Quotes are sourced from the NSE and the BSE. Key statistics were last updated on October 23, 2026. This page covers 10 balance sheet periods, 15 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.